Welcome to LookChem.com Sign In|Join Free

CAS

  • or

54149-39-2

Post Buying Request

54149-39-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

54149-39-2 Usage

Uses

O-2-Methoxyethylhydroxylamine can be prepared to use as antagonists of the adenosine A2a receptor to treat diseases or conditions in which the adenosine A2a receptor activity is implicated.

Check Digit Verification of cas no

The CAS Registry Mumber 54149-39-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,1,4 and 9 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 54149-39:
(7*5)+(6*4)+(5*1)+(4*4)+(3*9)+(2*3)+(1*9)=122
122 % 10 = 2
So 54149-39-2 is a valid CAS Registry Number.
InChI:InChI=1/C3H9NO2/c1-5-2-3-6-4/h2-4H2,1H3

54149-39-2Relevant articles and documents

Radical C(sp3)-H Heck-type Reaction of N-Alkoxybenzimidoyl Chlorides with Styrenes to Construct Alkenols

Chen, Yiyun,Fang, Di,Zhang, Yidan

supporting information, (2022/03/17)

We report the first radical C(sp3)-H Heck-type reaction of aliphatic alcohols for selective δ- and ?-alkenol synthesis by photoredox catalysis. N-Alkoxybenzimidoyl chlorides are developed as novel alkoxyl radical precursors with tunable redox potentials. Various alkenols can be constructed by the inert C(sp3)-H Heck-type reaction of 4-cyano-N-alkoxybenzimidoyl chlorides with styrene derivatives under redox-neutral conditions, which can be performed on the gram scale and can be easily derivatized.

OXIM DERIVATIVES AS HSP90 INHIBITORS

-

Page/Page column 153, (2009/09/05)

The invention relates to HSP90 inhibiting compounds consisting of the formula: (I) wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

CHEMOKINE RECEPTOR BINDING COMPOUNDS

-

Page/Page column 143, (2008/06/13)

The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. Thesd compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54149-39-2